Prospective randomized controlled trial of auricular point therapy in the treatment of diabetic patients with anxiety and depression

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100054421

Enrollment

Unknown

Registered

2021-12-17

Start date

2021-04-01

Completion date

Unknown

Last updated

2022-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus combined with anxiety and depression

Interventions

Experimental group:Basic therapy combined with auricular point comprehensive therapy

Control group:Basic therapy combined with routine ear pressure therapy

Eligibility

Sex/Gender

All

Age

30 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for type 2 diabetes; 2. Patients with mild to moderate anxiety and/or depression are indicated by the scale evaluation; 3. Aged 30 to 75 years; 4. Subjects or their families agreed and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Factors such as ear skin infection affect the operators of auricular comprehensive therapy; 2. Combined with more serious primary diseases of other organs or systems; 3. Can not cooperate with the operator of auricular comprehensive therapy.

Design outcomes

Primary

Measure	Time frame
Improvement rate of insomnia symptoms;	—

Secondary

Measure	Time frame
Traditional Chinese Medicine symptom score;Time within glucose target range;Fasting blood glucose;Blood glucose 2 hours after meal;	—

Countries

China

Contacts

Public ContactZhang Hong

Fangshan Hospital of Beijing University of Traditional Chinese Medicine

hong_xueming@sina.com+86 13911721600

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026